Drop-In Replacement For TCI B7018: 5-Bromo-2-Chloro-4'-Ethoxydiphenylmethane
COA Parameters for Trace Halogenated Impurities: Mitigating 4-Chloro-1-Ethoxybenzene Carryover to Prevent Palladium Catalyst Poisoning
In the synthesis of SGLT2 inhibitor intermediate routes, the integrity of the 5-Bromo-2-Chloro-4'-Ethoxydiphenylmethane (CAS: 461432-23-5) feedstock directly impacts downstream catalytic efficiency. Our engineering analysis focuses on the control of trace halogenated impurities, specifically 4-chloro-1-ethoxybenzene, which can arise from incomplete alkylation or hydrolysis during the manufacturing process. Field data indicates that when 4-chloro-1-ethoxybenzene exceeds 0.05%, it can coordinate with palladium species during the subsequent Suzuki-Miyaura coupling step. This coordination reduces the turnover frequency of the catalyst, often necessitating a 15-20% increase in catalyst loading to maintain target conversion rates. Our purification protocol for this Dapagliflozin precursor includes targeted distillation and crystallization steps designed to suppress this specific impurity profile, ensuring the organic building block does not compromise catalyst performance.
Furthermore, we have observed edge-case behavior regarding moisture sensitivity during storage. In environments with high relative humidity, trace moisture ingress can accelerate the hydrolysis of the ethoxy group, leading to the formation of phenolic byproducts. These byproducts can complicate downstream chromatography and affect the color of the final API. Our quality control measures include rigorous water content monitoring and the use of desiccant-lined packaging to maintain chemical stability. For detailed impurity profiles, please refer to the batch-specific COA provided with each shipment of high-purity 5-Bromo-2-Chloro-4'-Ethoxydiphenylmethane.
Strict Batch-to-Batch Purity Grades: Eliminating Mandatory Pre-Reaction Recrystallization to Save 12 to 18 Hours Per Commercial Synthesis Cycle
Consistency in purity grades is critical for process efficiency in high-volume manufacturing. Variability in intermediate quality often forces R&D and production teams to implement mandatory pre-reaction recrystallization steps, adding 12 to 18 hours to the synthesis cycle and increasing solvent consumption. NINGBO INNO PHARMCHEM CO.,LTD. maintains strict batch-to-batch control to deliver material that meets the specifications required for direct dissolution and reaction. By ensuring that the 5-Bromo-2-Chloro-4'-Ethoxydiphenylmethane arrives with consistent purity and particle size distribution, we enable procurement managers to eliminate unnecessary purification steps, thereby optimizing throughput and reducing operational costs.
The following table outlines the technical parameters for our intermediate, aligned with industry standards for pharmaceutical grade applications. These specifications support the seamless integration of our product into existing synthetic routes without process modification.
| Parameter | NINGBO INNO PHARMCHEM Specification | Reference Standard (TCI B7018) | Notes |
|---|---|---|---|
| Purity (HPLC) | ≥99.0% | ≥99.0% | Main peak area |
| Individual Impurities | ≤0.1% | ≤0.1% | Includes Purity A and B |
| Melting Point | 39-43°C | 39-43°C | Batch-dependent range |
| Water Content | ≤0.5% | ≤0.5% | Karl Fischer titration |
| Residue on Ignition | ≤1.0% | ≤1.0% | Inorganic salts |
| Appearance | White to off-white solid | White solid | Visual inspection |
For exact numerical values and chromatograms, please refer to the batch-specific COA. Our commitment to strict purity grades ensures that your production schedule remains uninterrupted by quality deviations.
Technical Specifications for Suzuki-Miyaura Couplings: Maintaining Peak Reaction Kinetics as a Drop-in Replacement for TCI B7018
Our 5-Bromo-2-Chloro-4'-Ethoxydiphenylmethane is engineered as a direct drop-in replacement for TCI B7018, offering identical technical parameters and reaction kinetics. This compatibility allows for immediate substitution in Suzuki-Miyaura couplings used in Dapagliflozin and Sotagliflozin synthesis without the need for re-validation of reaction conditions. Procurement managers can leverage this interchangeability to diversify supply chains and mitigate risks associated with single-source dependencies. Our product maintains the same solubility profile and reactivity, ensuring that reaction rates and yields remain consistent with established benchmarks.
From a field engineering perspective, we have noted that the crystal habit of the intermediate can influence dissolution rates in toluene/water biphasic systems. Variations in particle size can lead to localized concentration gradients, potentially causing hot spots and thermal degradation of the ethoxy moiety during exothermic coupling steps. Our milling process controls particle size distribution to ensure uniform dissolution, preventing these kinetic anomalies. This attention to physical properties supports stable reaction profiles and consistent product quality. By choosing our intermediate, you gain access to a reliable supply of high-purity chemical material that supports efficient manufacturing processes.
Bulk Packaging and Procurement Compliance: Streamlining Supply Chain Logistics for High-Volume Dapagliflozin Intermediate Manufacturing
Efficient logistics are essential for maintaining continuous production in pharmaceutical manufacturing. We offer flexible packaging options tailored to the needs of high-volume Dapagliflozin intermediate manufacturing. Standard configurations include 25kg fiber drums and 210L IBC totes, which are compatible with automated handling systems and reduce manual labor during unloading. For customers with specific warehouse requirements, we support custom packaging solutions to align with your operational workflows. All shipments are prepared with robust sealing and protective measures to prevent damage during transit.
Our logistics team coordinates shipping via standard freight methods, ensuring timely delivery to your facility. We provide detailed documentation, including packing lists and certificates of analysis, to facilitate smooth customs clearance and receipt processing. For inquiries regarding bulk price structures, tonnage availability, or custom packaging requests, please contact our sales department. We are committed to supporting your supply chain with reliable and efficient service.
Frequently Asked Questions
What are the HPLC peak purity thresholds for this intermediate?
Our standard specification requires a main peak purity of ≥99.0% by HPLC. Individual impurities are controlled to ≤0.1%. Detailed chromatograms and specific impurity profiles are provided in the batch-specific COA.
What are the heavy metal limits in the product?
Heavy metal content is monitored to ensure compliance with standard pharmaceutical intermediate requirements. Specific limits for metals such as palladium, nickel, and iron are detailed in the batch-specific COA. Please request the COA for exact values.
What is the direct substitution ratio for TCI B7018?
Our 5-Bromo-2-Chloro-4'-Ethoxydiphenylmethane is formulated as a 1:1 drop-in replacement for TCI B7018. No adjustment to stoichiometry or reaction conditions is required when switching suppliers.
Sourcing and Technical Support
NINGBO INNO PHARMCHEM CO.,LTD. provides comprehensive technical support and reliable supply chain solutions for 5-Bromo-2-Chloro-4'-Ethoxydiphenylmethane. Our team is available to assist with specification reviews, sample requests, and logistics coordination. Ready to optimize your supply chain? Reach out to our logistics team today for comprehensive specifications and tonnage availability.